Banu Şahin YILDIZ, Mustafa Ozan GÜRSOY

Kalp Dışı Cerrahi Girişim Uygulanacak Kalp Hastalarında Preoperatif Değerlendirme

Yaşlanan popülasyonun artmasının perioperatif tedavi üzerinde önemli bir etkisi olmaktadır. Cerrahi işlem sayısının her yaş grubunda arttığı gibi, en fazla artış orta yaş ve yaşlı popülasyonda görülmeye başlanmıştır. Kalp hastalıklarına bağlı mortalite genel popülasyonda azalmasına rağmen, iskemik kalp hastalığı, kalp yetersizliği ve başta diyabet olmak üzere kardiyovasküler risk faktörlerinde artış görülmektedir. Genel cerrahi yapılan yaşlı hastalarda en sık görülen komorbidite, kardiyovasküler hastalıktır. Kalp dışı cerrahi işlemlerin ardından gelişen kardiyak komplikasyonlar, yalnızca spesifi k risk faktörlerine bağlı değil, aynı zamanda cerrahinin türü ve cerrahinin yapıldığı koşullar ile de ilişkilidir. Bu derlemede kalp dışı cerrahi girişim uygulanacak kalp hastalarında preoperatif değerlendirmeyi özetlemeyi hedefledik.

Preoperative Cardiovascular Evaluation For Noncardiac Surgery

The increase in ageing of the population has a major impact on perioperative patient management. The number of surgical interventions increases in almost all age groups, but that the largest increase occurs in the middle aged and elderly population. Although mortality from cardiac disease is decreasing in the overall population, the prevalence of ischemic heart disease, heart failure and cardiovascular risk factors, especially diabetes mellitus, is increasing. Among the signifi cant co-morbidities in elderly patients presenting for general surgery, cardiovascular disease is the most prevalent. Cardiac complications after non-cardiac surgery depend not only on specifi c risk factors but also on the type of surgery and the circumstances under which it takes place. In this review, we aimed to summarize the preoperative cardiovascular evaluation for noncardiac surgery

PDF

___

Berkmen R. Kalb hastalıklarında kalb dışı cerrahi girişimler. In: Özcan R. Editör. Kalb hastalıkları. İstanbul: Sanal Matbaacılık Yayınevi, 1983;1005-9.
Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153-84.
Massie BM, Mangano DT. Assessment of perioperative risk: Risk stratifi cation for noncardiac surgery: How and why? Circulation 1993;87:1752-55.
Schlant RC, Eagle KA. Perioperative evaluation and management of patients with known or suspected cardiovascular disease who undergo noncardiac surgery. In: Alexander RW, Schlant RC, Fuster V (eds). Hurst's The Heart: Arteries and Veins, 9th ed. New York: McGraw-Hill, 1998;2243-55.
Khan GM. Kalp dışı cerrahi girişim uygulanacak kalp hastalarında preoperatuar hazırlık. In: Khan GM. (ed). Kalp hastalıkları tanı ve tedavisi. İstanbul: Turgut Yayıncılık, 2000;549-5.
Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110:859-66.
Eagle KA, Charanjit SR, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of noncardiac surgery: Infl uence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation 1997;96:1882-7.
Shaw L, Eagle KA, Gersh BJ, Miller DD. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratifi cation before vascular surgery. J Am Coll Cardiol 1996;27:787-98.
Bonow RO. Identifi cation of viable myocardium. Circulation 1996;94:2674-80.
Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF, et al. ACC / AHA guidelines for exercise testing: A report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997;30:260-311.
Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2007;50:e159-241.
Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-50.
Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, et al. Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery; European Society of Cardiology (ESC), Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009;30:2769-812.
Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9.
Boersma E, Kertai MD, Schouten O, Bax JJ, Noordzij P, Steyerberg EW, et al. Perioperative cardiovascular mortality in noncardiac surgery: Validation of the Lee cardiac risk index. Am J Med 2005;118:1134-41.
Rabbitts JA, Nuttall GA, Brown MJ, Hanson AC, Oliver WC, Holmes DR, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008;109:596-604.
Kazmers A, Cerqueira MD, Zierler RE. Perioperative and late outcome in patients with left ventricular ejection fraction of 35% or less who require major vascular surgery. J Vasc Surg 1988;8:307-15.
Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-9.
Feringa HH, Bax JJ, Schouten O, Poldermans D. Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardiac vascular surgery. Semin Cardiothorac Vasc Anesth 2006;10:25-31.
Weksler N, Klein M, Szendro G, Rozentsveig V, Schily M, Brill S, et al. The dilemma of immediate preoperative hypertension: To treat and operate, or to postpone surgery? J Clin Anesth 2003;15:179-83.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. The Task Force for the management of arterial hypertension of the European Society of Hypertension, the Task Force for the management of arterial hypertension of the European Society of C. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-536.
Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:247-346.
Bayliff CD, Massel DR, Inculet RI, Malthaner RA, Quinton SD, Powell FS, et al. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. Ann Thorac Surg 1999;67:182-6.
Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007;28:2256-95.
Madigan JD, Choudhri AF, Chen J, Spotnitz HM, Oz MC, Edwards N. Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference. Ann Surg 1999;230:639-47.
Vahanian A, Alfi eri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.
Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30:2369-413.
De Caterina R, Husted S, Wallentin L, Agnelli G, Bachmann F, Baigent C, et al. Anticoagulants in heart disease: Current status and perspectives. Eur Heart J 2007;28:880-913.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
Kertai MD, Boersma E, Bax JJ, van den Meiracker AH, vaIğdır Devlet Hastanesi, Kardiyoloji Kliniği, Iğdır, Türkiyen Urk H, Roelandt JR, et al. Comparison between serum creatinine and creatinine clearance for the prediction of postoperative mortality in patients undergoing major vascular surgery. Clin Nephrol 2003;59:17-23.